These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32749138)

  • 1. Current Development of Oral Taxane Formulations: A Review.
    Chowdhury N; Singh M
    Crit Rev Ther Drug Carrier Syst; 2020; 37(3):205-227. PubMed ID: 32749138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical review of lipid-based nanoparticles for taxane delivery.
    Feng L; Mumper RJ
    Cancer Lett; 2013 Jul; 334(2):157-75. PubMed ID: 22796606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel and its formulations.
    Singla AK; Garg A; Aggarwal D
    Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of alternative pharmaceutical formulations of taxanes.
    Nuijen B; Bouma M; Schellens JH; Beijnen JH
    Invest New Drugs; 2001 May; 19(2):143-53. PubMed ID: 11392448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on taxane development: new analogs and new formulations.
    Yared JA; Tkaczuk KH
    Drug Des Devel Ther; 2012; 6():371-84. PubMed ID: 23251087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of taxanes.
    Malingré MM; Beijnen JH; Schellens JH
    Invest New Drugs; 2001 May; 19(2):155-62. PubMed ID: 11392449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and drug release property of paclitaxel nanoparticles].
    Wang TW; Wu Y; Li MJ; Gao HX
    Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics.
    Ashrafizadeh M; Ahmadi Z; Mohamadi N; Zarrabi A; Abasi S; Dehghannoudeh G; Tamaddondoust RN; Khanbabaei H; Mohammadinejad R; Thakur VK
    Int J Biol Macromol; 2020 Feb; 145():282-300. PubMed ID: 31870872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the new strategy for the oral formulations of taxanes: changing the method with the situation.
    Wang HL; Sun J; Tian CT; He ZG
    Chin J Nat Med; 2021 Sep; 19(9):656-665. PubMed ID: 34561076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance.
    Kaushik L; Srivastava S; Panjeta A; Chaudhari D; Ghadi R; Kuche K; Malik R; Preet S; Jain S; Raza K
    Int J Pharm; 2020 Mar; 578():119088. PubMed ID: 32001291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
    Tsallas A; Jackson J; Burt H
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):431-44. PubMed ID: 21069339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
    Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
    Patel K; Patil A; Mehta M; Gota V; Vavia P
    Int J Pharm; 2014 Sep; 472(1-2):214-23. PubMed ID: 24954663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of polymer-lipid nanoparticles for docetaxel delivery.
    Albano JMR; Ribeiro LNM; Couto VM; Barbosa Messias M; Rodrigues da Silva GH; Breitkreitz MC; de Paula E; Pickholz M
    Colloids Surf B Biointerfaces; 2019 Mar; 175():56-64. PubMed ID: 30517905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of ultrasound to increase the uptake and cytotoxicity of dual taxane and P-glycoprotein inhibitor loaded, solid core nanoparticles in drug resistant cells.
    Jackson J; Leung D; Burt H
    Ultrasonics; 2020 Feb; 101():106033. PubMed ID: 31561207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved oral delivery of paclitaxel following administration in nanoemulsion formulations.
    Tiwari SB; Amiji MM
    J Nanosci Nanotechnol; 2006; 6(9-10):3215-21. PubMed ID: 17048539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
    Wang X; Guo Y; Qiu L; Wang X; Li T; Han L; Ouyang H; Xu W; Chu K
    Carbohydr Polym; 2019 Feb; 206():121-131. PubMed ID: 30553305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes.
    Beg S; Kaur R; Khurana RK; Rana V; Sharma T; Singh B
    AAPS PharmSciTech; 2019 Feb; 20(3):118. PubMed ID: 30790136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.